Positions

Selected Publications

Chapter

Year Title Altmetric
2013 Polycystic and other cystic kidney diseases.  362-370. 2013

Research Overview

  • IgA nephropathy
    Glomerulonephritis
    ADPKD
  • Principal Investigator On

  • Private Grant  awarded by CALLIDITAS THERAPEUTICS AB 2019 - 2026
  • Private Grant  awarded by REATA PHARMACEUTICALS 2019 - 2024
  • Private Grant  awarded by RETROPHIN, INC. 2019 - 2024
  • Private Grant  awarded by ACHILLION PHARMACEUTICALS INC 2018 - 2022
  • Private Grant  awarded by REATA PHARMACEUTICALS 2018 - 2022
  • Private Grant  awarded by REATA PHARMACEUTICALS 2019 - 2021
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2019 - 2021
  • Private Grant  awarded by REATA PHARMACEUTICALS 2017 - 2020
  • Private Grant  awarded by ABBVIE INC 2015 - 2018
  • A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)  awarded by MAYO CLINIC 2013 - 2018
  • Private Grant  awarded by FAST BIOMEDICAL 2017
  • Private Grant  awarded by NEPHROGENEX, INC. 2015 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2015
  • Private Grant  awarded by FAST BIOMEDICAL 2013 - 2014
  • Private Grant  awarded by REATA PHARMACEUTICALS 2011 - 2013
  • Private Grant  awarded by REATA PHARMACEUTICALS 2012
  • Private Grant  awarded by AMGEN, INC. 2007 - 2012
  • Private Grant  awarded by REATA PHARMACEUTICALS 2009 - 2010
  • Education And Training

  • Doctor of Medicine, 1997
  • St. Louis University Hospitals, Internship 1999
  • American University of Beirut Medical Center, Internship 1998
  • Emory University Hospital Systems, Residency 2001
  • St. Louis University Hospitals, Residency 2000
  • Emory University Hospital Systems, Postdoctoral Fellowship 2005
  • Full Name

  • Dana Rizk